[Drug therapy of cholelithiasis].
D007611:Aprotinin / Q000627:therapeutic use*; D001285:Atropine / Q000627:therapeutic use*; D002769:Cholelithiasis / Q000188:drug therapy*; D006801:Humans; D004091:Hydromorphone / Q000627:therapeutic use*; D010195:Pancreatitis / Q000188:drug therapy
D001285:Atropine; D007611:Aprotinin; D004091:Hydromorphone
Medikamentöse Therapie der Cholelithiasis.